-
.
- eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention. .
- msnbc host chris hayes says that trump asked gates this twice: once at their meeting in 2017, and again at their meeting in 2018. .
- © 2018 southern california public radio
connect with kpcc
-
.
.
.